Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
JBIO on Nasdaq
There are no Buy or Sell transactions made by DAVID S. GRAYZEL since 03 Feb 2025
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1,784,730 |
$50,240,150 |
$28.15 |
09 Apr 2024 |
By Atlas Venture Fund XII, L.P. |
|
|
| Common Stock |
14,502 |
$408,231 |
$28.15 |
09 Apr 2024 |
By Atlas Venture Associates XII, L.P. |
|
|
| Stock Option (Right to Buy) |
12,500 |
$204,625 |
$16.37 |
05 Jun 2024 |
Direct |
Common Stock |
|
Transactions reported by DAVID S. GRAYZEL for Jade Biosciences, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.